Moon Capital Management Has Trimmed Position in Cvs Health Com (CVS) by $309.26 Million; Autus Asset Management Has Lifted Position in General Dynamics (GD) as Market Valuation Declined

General Dynamics Corporation (NYSE:GD) Logo

Autus Asset Management Llc increased its stake in General Dynamics Corp (GD) by 7.49% based on its latest 2018Q3 regulatory filing with the SEC. Autus Asset Management Llc bought 2,136 shares as the company’s stock declined 12.00% with the market. The institutional investor held 30,645 shares of the marine transportation company at the end of 2018Q3, valued at $6.27 million, up from 28,509 at the end of the previous reported quarter. Autus Asset Management Llc who had been investing in General Dynamics Corp for a number of months, seems to be bullish on the $50.22B market cap company. The stock increased 0.69% or $1.2 during the last trading session, reaching $173.96. About 518,073 shares traded. General Dynamics Corporation (NYSE:GD) has declined 13.97% since February 13, 2018 and is downtrending. It has underperformed by 13.97% the S&P500. Some Historical GD News: 21/04/2018 – DJ General Dynamics Corporation, Inst Holders, 1Q 2018 (GD); 18/03/2018 – Singapore News: [CNA] CACI seeks to break up General Dynamics’ acquisition of CSRA; 20/03/2018 – General Dynamics ups offer in battle for CSRA; 25/04/2018 – GENERAL DYNAMICS CORP CEO SAYS WELL OVER 50 ORDERS ON THE G500 AND NEAR 50 ON G600 BUSINESS JETS; 23/05/2018 – General Dynamics Chairman and CEO Novakovic to Speak at Bernstein’s 34th Annual Strategic Decisions Conference; 22/03/2018 – GENERAL DYNAMICS FILES DEBT SECURITIES SHELF; 11/05/2018 – Fitch Plans to Withdraw Ratings of General Dynamics Corp. for Commercial Reasons; 03/04/2018 – General Dynamics Completes Acquisition of CSRA Inc. for $9.7B; 25/04/2018 – GENERAL DYNAMICS 1Q EPS CONT OPS $2.65, EST. $2.48; 28/03/2018 – While CACI has been trying to scale up through acquisitions, General Dynamics expects a deal with CSRA to help grab more of the U.S. defense budget

Moon Capital Management Llc decreased its stake in Cvs Health Corp Com (CVS) by 6.48% based on its latest 2018Q3 regulatory filing with the SEC. Moon Capital Management Llc sold 3,890 shares as the company’s stock declined 3.04% with the market. The institutional investor held 56,125 shares of the medical and nursing services company at the end of 2018Q3, valued at $4.46 billion, down from 60,015 at the end of the previous reported quarter. Moon Capital Management Llc who had been investing in Cvs Health Corp Com for a number of months, seems to be less bullish one the $87.42 billion market cap company. The stock increased 0.88% or $0.59 during the last trading session, reaching $67.6. About 4.63M shares traded. CVS Health Corporation (NYSE:CVS) has risen 3.17% since February 13, 2018 and is uptrending. It has outperformed by 3.17% the S&P500. Some Historical CVS News: 14/03/2018 – The BCBS Institute will test the pharmacy rides at select Walgreens locations in Chicago and select CVS locations in Pittsburgh; 09/04/2018 – TABLE-CVS Bay 2687.T -2017/18 parent forecast; 11/04/2018 – CVS rolls out new tool to combat rising drug prices; 13/03/2018 – CVS, Aetna shareholders will vote on deal Tuesday; 19/03/2018 – ClinicalTrial US: Applying Nutrient Drink Test in Understanding Pathophysiology of CVS; 11/04/2018 – CVS unveils a tool that makes it easier to find less expensive drugs; 04/04/2018 – CVS TO INITIATE TRIAL TO SHOW EFFICACY OF HEMODIALYSIS DEVICE; 04/04/2018 – Berger & Montague, P.C.: False Claims Act Case Against Caremark (CVS Health) Unsealed; 13/04/2018 – CVS MinuteClinics hires a new chief medical officer in the midst of buying Aetna; 13/04/2018 – CVS Health Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of MinuteClinic and Associate Chief Medical Officer o

Moon Capital Management Llc, which manages about $166.36 million and $100.12 billion US Long portfolio, upped its stake in Berkshire Hathaway Inc Del Cl A (BRKA) by 1 shares to 5 shares, valued at $1.61 billion in 2018Q3, according to the filing. It also increased its holding in International Business Machs Com (NYSE:IBM) by 35 shares in the quarter, for a total of 2,535 shares, and has risen its stake in Microsoft Corp Com (NASDAQ:MSFT).

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 14. They expect $2.14 earnings per share, up 11.46% or $0.22 from last year’s $1.92 per share. CVS’s profit will be $2.77B for 7.90 P/E if the $2.14 EPS becomes a reality. After $1.73 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 23.70% EPS growth.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS Health: This Despised Blue Chip Offers Market-Beating Total Return Potential – Seeking Alpha” on February 12, 2019, also 247Wallst.com with their article: “Top Analyst Upgrades and Downgrades: Alcoa, Cars.com, CVS, Electronic Arts, Halliburton, PNC, Salesforce, Walgreens, UnitedHealth and More – 24/7 Wall St.” published on January 17, 2019, Seekingalpha.com published: “CVS inks new PBM contract with Walmart – Seeking Alpha” on January 18, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Benzinga.com and their article: “Raymond James: CVS (NYSE:CVS) A Strong Buy Despite Pricing Headwinds – Benzinga” published on January 15, 2019 as well as Finance.Yahoo.com‘s news article titled: “Bulls & Bears Of The Week: CVS, EA, GM, Kinder Morgan And More – Yahoo! Finance News” with publication date: January 20, 2019.

Since August 27, 2018, it had 0 insider purchases, and 9 sales for $34.16 million activity. MERLO LARRY J sold $10.73M worth of stock. The insider Denton David M sold $2.02 million. Bisaccia Lisa had sold 21,534 shares worth $1.72M. On Monday, October 1 the insider Boratto Eva C sold $354,080. Hourican Kevin also sold $642,300 worth of CVS Health Corporation (NYSE:CVS) shares. 77,639 shares were sold by Roberts Jonathan C, worth $5.01 million.

Among 28 analysts covering CVS Health (NYSE:CVS), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. CVS Health had 86 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Robert W. Baird on Monday, September 25. The firm has “Neutral” rating given on Friday, November 3 by Citigroup. Goldman Sachs downgraded the stock to “Neutral” rating in Thursday, December 17 report. Citigroup maintained the stock with “Neutral” rating in Monday, May 9 report. The firm earned “Buy” rating on Tuesday, August 8 by Oppenheimer. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Cantor Fitzgerald on Monday, November 26. On Friday, August 28 the stock rating was maintained by Oppenheimer with “Outperform”. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Wednesday, January 17 by Robert W. Baird. The firm earned “Buy” rating on Thursday, January 4 by Raymond James. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Friday, September 8 by Needham.

Investors sentiment increased to 1.12 in Q3 2018. Its up 0.05, from 1.07 in 2018Q2. It is positive, as 76 investors sold CVS shares while 459 reduced holdings. 144 funds opened positions while 456 raised stakes. 828.14 million shares or 1.36% more from 816.99 million shares in 2018Q2 were reported. Summit Gru Ltd Liability invested 0.21% of its portfolio in CVS Health Corporation (NYSE:CVS). Inv House Ltd Limited Liability Company has 26,835 shares. Van Eck Associate Corp holds 418,058 shares or 0.16% of its portfolio. Van Hulzen Asset Llc reported 2,712 shares. Cidel Asset Mngmt has 171,553 shares. Alliancebernstein LP holds 2.48 million shares. Marshall Wace Llp has invested 0.07% in CVS Health Corporation (NYSE:CVS). Adell Harriman Carpenter Inc reported 0% of its portfolio in CVS Health Corporation (NYSE:CVS). Community Bancshares Na reported 21,535 shares or 0.33% of all its holdings. Colrain Capital Ltd Liability Corp has 78,985 shares. Tiedemann Advisors Limited Company invested in 0.05% or 10,970 shares. South Dakota Invest Council has 121,075 shares for 0.21% of their portfolio. Horan Cap Advisors Ltd Liability Co invested in 1.61% or 31,704 shares. Lpl Finance Limited Liability Co invested in 348,590 shares or 0.07% of the stock. Monetta Financial Services owns 10,000 shares for 0.48% of their portfolio.

Investors sentiment increased to 1.08 in Q3 2018. Its up 0.18, from 0.9 in 2018Q2. It is positive, as 57 investors sold GD shares while 286 reduced holdings. 91 funds opened positions while 278 raised stakes. 229.88 million shares or 0.59% more from 228.52 million shares in 2018Q2 were reported. New Jersey Better Educational Savings Trust stated it has 1,400 shares. Webster Fincl Bank N A invested 0.49% in General Dynamics Corporation (NYSE:GD). Sabal Trust reported 1,125 shares or 0.02% of all its holdings. Moreover, Cap Investors has 1.23% invested in General Dynamics Corporation (NYSE:GD) for 20.71 million shares. Winslow Capital Mgmt Limited Liability accumulated 237 shares. 1,155 were accumulated by Gateway Advisory Ltd Liability Corporation. The Washington-based Fisher Asset Management Limited Liability Company has invested 0% in General Dynamics Corporation (NYSE:GD). Longview Asset Mngmt Ltd Liability Corporation has invested 97.72% in General Dynamics Corporation (NYSE:GD). Florida-based State Board Of Administration Of Florida Retirement Systems has invested 0.18% in General Dynamics Corporation (NYSE:GD). Blackrock Inc has 17.45 million shares for 0.15% of their portfolio. Willingdon Wealth Mngmt invested 0% of its portfolio in General Dynamics Corporation (NYSE:GD). Natixis Lp has 0.32% invested in General Dynamics Corporation (NYSE:GD) for 176,013 shares. Texas Yale holds 0.13% of its portfolio in General Dynamics Corporation (NYSE:GD) for 8,038 shares. Regions Financial holds 0.07% or 33,047 shares. Dakota Wealth Mngmt owns 2,405 shares.

Autus Asset Management Llc, which manages about $447.84 million and $603.20 million US Long portfolio, decreased its stake in Mccormick & Co Inc (NYSE:MKC) by 2,907 shares to 96,941 shares, valued at $12.77 million in 2018Q3, according to the filing. It also reduced its holding in Intuit (NASDAQ:INTU) by 3,783 shares in the quarter, leaving it with 50,103 shares, and cut its stake in Vanguard Index Fds (VOO).

Among 23 analysts covering General Dynamics Corporation (NYSE:GD), 11 have Buy rating, 2 Sell and 10 Hold. Therefore 48% are positive. General Dynamics Corporation had 93 analyst reports since July 31, 2015 according to SRatingsIntel. As per Tuesday, August 25, the company rating was downgraded by Zacks. The stock has “Buy” rating by Jefferies on Friday, October 13. As per Friday, June 22, the company rating was maintained by Morgan Stanley. RBC Capital Markets maintained General Dynamics Corporation (NYSE:GD) on Wednesday, November 15 with “Buy” rating. Robert W. Baird maintained the shares of GD in report on Thursday, October 25 with “Outperform” rating. Argus Research downgraded the stock to “Hold” rating in Thursday, January 31 report. The firm has “Outperform” rating given on Monday, January 30 by RBC Capital Markets. The rating was maintained by Credit Suisse with “Outperform” on Thursday, October 25. The company was maintained on Tuesday, May 22 by Credit Suisse. On Thursday, October 26 the stock rating was maintained by Stifel Nicolaus with “Hold”.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart